Therefore, increased IGF2 levels will be caused by loss of function mutations of IGFBP2. Remarkably, impaired glycogenolysis and gluconeogenesis with consequent hypoglycemia and suppressed insulin secretion have been found in patients with IGF2-producing tumors. Here, INS is linked to Hypoglycemia.